Speaker Profile

Executive Summary：
Dr. Ruei-Yi Tai graduated from the College of Medicine, National Taiwan University, and received her neurological residency training at Taipei Medical University Hospital (TMUH).

Dr. Tai is now an attending physician at Taipei Medical University Hospital. His main academic interests focus on Parkinson's disease and other movement disorders. His ongoing research leverages artificial intelligence approaches to investigate neurodegenerative alterations associated with Parkinson’s disease. He is now the treasurer of Taiwan Movement Disorders Society (TMDS).

Lecture Abstract：

Executive Summary：
Dr. Chiang graduated from Taipei Medical University and completed her neurology residency at Chang Gung Memorial Hospital. She subsequently served as an attending neurologist in the Department of Neurology at Taipei Tzu Chi General Hospital, before joining Taipei Veterans General Hospital in 2018.

She completed a clinical fellowship in movement disorders at the Movement Disorders Unit of Westmead Hospital under the mentorship of Prof. Victor Fung from 2014 to 2015. Following her training in Sydney, she pursued a master’s degree at National Taiwan University under the supervision of Prof. Chin-Hsien Lin.

Her major research interests focus on the genetics of Parkinson’s disease and other movement disorders, as well as non-pharmacological interventions.

Lecture Abstract：
This talk will focus on cognitive impairment in Parkinson’s disease (PD), with particular emphasis on its overlap with Alzheimer’s disease (AD). Rather than viewing PD-related cognitive decline as a consequence of alpha-synuclein alone, increasing evidence suggests that coexisting Alzheimer-related pathologies, including amyloid-beta and tau protein, play an important role in shaping clinical presentation and disease progression. The talk will outline how this pathological crosstalk may contribute to cognitive heterogeneity in PD, and will briefly review current approaches to detecting and characterizing these overlapping processes. The goal is to provide a conceptual framework for understanding PD-related cognitive impairment as a result of interacting neurodegenerative pathways, with implications for future research and therapeutic development.